__________________________________________________________________________________________
Re: Global ID / Local ID: TH201408008944/ TH140803456 FU (2)
Thank you for reporting to us an adverse event related to Lilly product(s).
We would like to collect more information to better understanding the reported event.
Please respond to following question regarding the adverse event – burning sensation in her chest, involving a female patient, age 63, who was subscribed Forteo, reported the event to Lilly on 22-Aug-2014.
Please provide the informatoin for following:
1. What was the reason for the surgery performed on 22Oc2014? Is there information available about the diagnosis of the case?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
2. Could the “numbness in leg” and “unable to bend the knee” be expected conditions after the surgery? Or should be considered adverse events? Was a corrective treatment introduced? Did the patient recover?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
3. Does the physician have a relatedness opinion for the events? (including Burning sensation in her chest, Dizziness, Bloating and Nausea, occurred prior to surgery)
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
4. What were the concomitant medications of patient?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: